Emergent BioSolutions Inc. 4
4 · Emergent BioSolutions Inc. · Filed Sep 28, 2009
Insider Transaction Report
Form 4
Keese Kyle
SVP, Mfg Ops
Transactions
- Other
Common Stock
2009-05-29+5,040→ 5,336 total - Sale
Common Stock
2009-09-15−5,000→ 336 total
Footnotes (1)
- [F1]Pro rata distribution from BioPharm, L.L.C., of which the reporting person is a non-managing director.